Ventyx Biosciences, Inc. (VTYX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -17.51M | -21.28M | -25.72M | -23.25M | -35.46M | -24.54M | -47.63M | -51.66M | -34.66M | -49.28M | -30.92M | -47.26M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 50.63% | 13.29% | 46% | 54.99% | -2.3% | 50.21% | -54.02% | -9.29% | -44.5% | -233.17% | -142.97% | -221.57% |
| Net Income | -22.83M | -26.99M | -27.44M | -29.35M | -35.25M | -31.95M | -38.57M | -46.75M | -54.03M | -53.25M | -38.93M | -35.21M |
| Depreciation & Amortization | 326K | 323K | 356K | 315K | 309K | 316K | 408K | 403K | 265K | 139K | 134K | 150K |
| Stock-Based Compensation | 4.6M | 4.58M | 5.03M | 5.17M | 5.45M | 5.77M | 6.54M | 6.14M | 8.01M | 7.87M | 6.57M | 4.83M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.54M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.06M | -1.31M | -1.59M | -2.08M | -2.61M | -2.75M | -2.03M | 8.34M | -2.13M | -2.49M | -2.08M | -1.73M |
| Working Capital Changes | 1.46M | 2.13M | -2.07M | 2.7M | -3.36M | 4.07M | -13.97M | -9.26M | 13.22M | -1.55M | 3.39M | -15.29M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 101K | -1.43M | -809K | 824K | -4.3M | 2.02M | -1.19M | -3.58M | 5.21M | -2.28M | -91K | -8.26M |
| Cash from Investing | 17.05M | 25.19M | 26.41M | -11M | 29.25M | -75.52M | 41.77M | 46.13M | 38.89M | 34.82M | -18.89M | -140.84M |
| Capital Expenditures | -50K | -42K | -16K | -6K | 0 | -60K | -175K | -211K | -48K | -195K | -60K | -112K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -46.34K | -38.94K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.34K | 38.94K | 0 | 0 | 0 |
| Cash from Financing | 203K | 68K | 0 | -25K | 26.86M | -906K | 96.18M | 585K | 1.63M | 2.47M | 48.65M | -10.36M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 68K | 0 | -247K | 1000K | -1000K | 1000K | 585K | 1000K | -47K | 1000K | -1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 68K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 203K | 0 | 0 | 222K | 0 | 140K | 92K | 0 | 0 | 2.52M | 191K | 777K |
| Net Change in Cash | -331K | 4.22M | 816K | -34.51M | 20.84M | -100.97M | 90.32M | -5.03M | 5.87M | -11.95M | -1.15M | -198.45M |
| Free Cash Flow | -17.56M | -21.32M | -25.73M | -23.25M | -35.46M | -24.6M | -47.8M | -51.87M | -34.71M | -49.48M | -30.98M | -47.38M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 50.49% | 13.33% | 46.16% | 55.16% | -2.16% | 50.28% | -54.29% | -9.48% | -44.12% | -233.85% | -142.72% | -221.28% |
| FCF per Share | -0.25 | -0.30 | -0.36 | -0.33 | -0.50 | -0.35 | -0.77 | -0.88 | -0.59 | -0.84 | -0.54 | -0.84 |
| FCF Conversion (FCF/Net Income) | 0.77x | 0.79x | 0.94x | 0.79x | 1.01x | 0.77x | 1.23x | 1.10x | 0.64x | 0.93x | 0.79x | 1.34x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |